Published in Am J Psychiatry on November 01, 1993
Validity of the prodromal risk syndrome for first psychosis: findings from the North American Prodrome Longitudinal Study. Schizophr Bull (2009) 2.90
Psychiatric comorbidities and schizophrenia. Schizophr Bull (2008) 2.69
Patterns of stress in schizophrenia. Psychiatry Res (2008) 1.55
The early course of schizophrenia and depression*. Eur Arch Psychiatry Clin Neurosci (2005) 1.07
Psychological pathways to depression in schizophrenia: studies in acute psychosis, post psychotic depression and auditory hallucinations. Eur Arch Psychiatry Clin Neurosci (2005) 1.00
Failure of neural responses to safety cues in schizophrenia. Arch Gen Psychiatry (2012) 0.99
Kraepelin and psychotic prodromal conditions. Eur Arch Psychiatry Clin Neurosci (2008) 0.96
Depression in the long-term course of schizophrenia. Eur Arch Psychiatry Clin Neurosci (2005) 0.92
The relationships between depression and remission in first-episode psychosis. World Psychiatry (2006) 0.90
Emotional modulation of response inhibition in stable patients with bipolar I disorder: a comparison with healthy and schizophrenia subjects. Bipolar Disord (2011) 0.88
Depression, suicidal behavior and insight in adolescents with schizophrenia. Eur Child Adolesc Psychiatry (2006) 0.87
Does self-perceived mood predict more variance in cognitive performance than clinician-rated symptoms in schizophrenia? Schizophr Bull (2006) 0.81
Relations between movement disorders and psychopathology under predominantly atypical antipsychotic treatment in adolescent patients with schizophrenia. Eur Child Adolesc Psychiatry (2007) 0.81
Structural differences within negative and depressive syndrome dimensions in schizophrenia, organic brain disease, and major depression: A confirmatory factor analysis of the positive and negative syndrome scale. Psychopathology (2009) 0.80
Forms of antipsychotic therapy: improved individual outcomes under personalised treatment of schizophrenia focused on depression. EPMA J (2011) 0.80
Prominent clinical dimension, duration of illness and treatment response in schizophrenia: a naturalistic study. Psychiatry Investig (2012) 0.77
The prevalence of substance use disorders and psychiatric disorders as a function of psychotic symptoms. Drug Alcohol Depend (2013) 0.77
The treatment of schizophrenia: from premorbid manifestations to the first episode of psychosis. Dialogues Clin Neurosci (2005) 0.77
Elderly patients with schizophrenia and depression: diagnosis and treatment. Clin Schizophr Relat Psychoses (2011) 0.77
Cognitive alexithymia is associated with the degree of risk for psychosis. PLoS One (2015) 0.76
Augmentation with antidepressants in schizophrenia treatment: benefit or risk. Neuropsychiatr Dis Treat (2015) 0.76
Relationship between Antidepressant Prescription Rates and Features of Schizophrenic Patients and Its Outcome in Schizophrenia Treatment. Noro Psikiyatr Ars (2015) 0.75
Cognitive impairments, emotion, stress, and language in schizophrenia. Psychiatry Res (2009) 0.75
First-episode schizophrenia and depression. Am J Psychiatry (1995) 0.75
Severity of psychotic episodes in predicting concurrent depressive and anxiety features in acute phase schizophrenia. BMC Psychiatry (2014) 0.75
Negative symptoms and their association with depressive symptoms in the long-term course of schizophrenia. Eur Arch Psychiatry Clin Neurosci (2016) 0.75
Elevation of serum angiotensin-converting-enzyme (ACE) level in sarcoidosis. Am J Med (1975) 5.41
Effector differentiation is not prerequisite for generation of memory cytotoxic T lymphocytes. J Clin Invest (2001) 4.37
Genomewide association for schizophrenia in the CATIE study: results of stage 1. Mol Psychiatry (2008) 4.14
Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Arch Gen Psychiatry (1999) 3.48
Efficacy and safety of troglitazone in the treatment of lipodystrophy syndromes. Ann Intern Med (2000) 3.44
Comparative side effects of imipramine, benztropine, or their combination in patients receiving fluphenazine decanoate. Am J Psychiatry (1983) 3.23
Heterozygous and homozygous alpha-antitrypsin deficiency in patients with pulmonary emphysema. N Engl J Med (1969) 3.19
Statistical shape analysis of neuroanatomical structures based on medial models. Med Image Anal (2003) 3.17
The Kaposi sarcoma-associated herpesvirus (KSHV) is present as an intact latent genome in KS tissue but replicates in the peripheral blood mononuclear cells of KS patients. J Exp Med (1996) 2.67
Conditions that mimic stroke in the emergency department. Implications for acute stroke trials. Arch Neurol (1995) 2.66
Impaired function of circulating HIV-specific CD8(+) T cells in chronic human immunodeficiency virus infection. Blood (2000) 2.65
Abnormalities of the septum pellucidum on MR scans in first-episode schizophrenic patients. AJNR Am J Neuroradiol (1992) 2.58
Control of HIV despite the discontinuation of antiretroviral therapy. N Engl J Med (1999) 2.54
Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials. Am J Psychiatry (2001) 2.35
Human cardiovascular and metabolic response to acute, severe isovolemic anemia. JAMA (1998) 2.16
The silent treatment: siRNAs as small molecule drugs. Gene Ther (2006) 2.12
Predictors of treatment response from a first episode of schizophrenia or schizoaffective disorder. Am J Psychiatry (1999) 2.06
Serum angiotensin-converting enzyme for diagnosis and therapeutic evaluation of sarcoidosis. Am Rev Respir Dis (1979) 2.04
Molecular abnormality of human alpha1-antitrypsin variant (Pi-ZZ) associated with plasma activity deficiency. Proc Natl Acad Sci U S A (1976) 2.00
Zalcitabine compared with zidovudine in patients with advanced HIV-1 infection who received previous zidovudine therapy. Ann Intern Med (1993) 1.99
The early stages of schizophrenia: speculations on pathogenesis, pathophysiology, and therapeutic approaches. Biol Psychiatry (2001) 1.94
Longitudinal study of brain morphology in first episode schizophrenia. Biol Psychiatry (2001) 1.86
Huntington's disease in Venezuela: 7 years of follow-up on symptomatic and asymptomatic individuals. Mov Disord (1990) 1.76
Variants of alpha 1-antitrypsin in Puerto Rican children with asthma. Chest (1993) 1.75
CD8 T cells specific for human immunodeficiency virus, Epstein-Barr virus, and cytomegalovirus lack molecules for homing to lymphoid sites of infection. Blood (2001) 1.74
Imaging endogenous dopamine competition with [11C]raclopride in the human brain. Synapse (1994) 1.68
Alpha 1 -antitrypsin (A1AT) accumulation in livers of emphysematous patients with A1AT deficiency. Hum Pathol (1972) 1.64
A transgenic mouse model to analyze CD8(+) effector T cell differentiation in vivo. Proc Natl Acad Sci U S A (1999) 1.62
Alpha 1-antitrypsin Pi-types in 965 COPD patients. Chest (1986) 1.61
Provocative tests with psychostimulant drugs in schizophrenia. Psychopharmacology (Berl) (1987) 1.60
Alpha 1 antitrypsinin the livers of patients with emphysema. Science (1972) 1.49
Absence of recoverable infectious virus and unique immune responses in an asymptomatic HIV+ long-term survivor. AIDS Res Hum Retroviruses (1994) 1.45
Alpha(1)-antitrypsin deficiency. Calif Med (1973) 1.45
Caudate nuclei volumes in schizophrenic patients treated with typical antipsychotics or clozapine. Lancet (1995) 1.43
Granzyme A loading induces rapid cytolysis and a novel form of DNA damage independently of caspase activation. Immunity (1999) 1.42
Real-life basis for a patient's paranoia. Am J Psychiatry (1991) 1.40
Perforin is not co-expressed with granzyme A within cytotoxic granules in CD8 T lymphocytes present in lymphoid tissue during chronic HIV infection. AIDS (1999) 1.40
Time course and biologic correlates of treatment response in first-episode schizophrenia. Arch Gen Psychiatry (1993) 1.40
Thyroid releasing hormone test in schizophrenic patients with post-psychotic depression. Prog Neuropsychopharmacol Biol Psychiatry (1991) 1.39
Factors influencing treatment response and outcome of first-episode schizophrenia: implications for understanding the pathophysiology of schizophrenia. J Clin Psychiatry (1996) 1.39
Human immunodeficiency virus-specific circulating CD8 T lymphocytes have down-modulated CD3zeta and CD28, key signaling molecules for T-cell activation. J Virol (2000) 1.38
Identification and characteristics of the common alpha 1 -antitrypsin phenotypes. Chest (1972) 1.36
Elevation of serum angiotensin-converting enzyme in Gaucher's disease. N Engl J Med (1976) 1.35
Induction of cell-mediated immune responses to human immunodeficiency virus type 1 Gag protein by using Listeria monocytogenes as a live vaccine vector. J Immunol (1995) 1.34
Alpha 1 -antitrypsin deficiency. Med Clin North Am (1973) 1.32
Mitochondria-dependent and -independent regulation of Granzyme B-induced apoptosis. J Exp Med (1999) 1.31
A new deficient variant of alpha1-antitrypsin (MDUARTE). Inability to detect the heterozygous state by antitrypsin phenotyping. Am Rev Respir Dis (1976) 1.29
Relationship between psychostimulant-induced "high" and dopamine transporter occupancy. Proc Natl Acad Sci U S A (1996) 1.27
Granzyme A activates an endoplasmic reticulum-associated caspase-independent nuclease to induce single-stranded DNA nicks. J Biol Chem (2001) 1.25
Tardive dyskinesia: prevalence, incidence, and risk factors. J Clin Psychopharmacol (1988) 1.22
Special delivery: targeted therapy with small RNAs. Gene Ther (2011) 1.22
Treatment of human immunodeficiency virus infection with hydroxyurea, didanosine, and a protease inhibitor before seroconversion is associated with normalized immune parameters and limited viral reservoir. J Infect Dis (1999) 1.21
Effects of clozapine, olanzapine, risperidone, and haloperidol on hostility among patients with schizophrenia. Psychiatr Serv (2001) 1.21
Effects of methylphenidate on regional brain glucose metabolism in humans: relationship to dopamine D2 receptors. Am J Psychiatry (1997) 1.21
The specificity and nature of serum-angiotensin-converting enzyme (serum ACE) elevations in sarcoidosis. Ann N Y Acad Sci (1976) 1.21
Usefulness of blood culture for hospitalized patients who are receiving antibiotic therapy. Clin Infect Dis (2001) 1.20
Prevalence and clinical correlates of extrapyramidal signs and spontaneous dyskinesia in never-medicated schizophrenic patients. Am J Psychiatry (1995) 1.19
Viral-specific cytotoxic T lymphocytes lyse human immunodeficiency virus-infected primary T lymphocytes by the granule exocytosis pathway. Blood (1999) 1.19
Integrating incidence and prevalence of tardive dyskinesia. Psychopharmacol Bull (1986) 1.17
Direct cleavage of the human DNA fragmentation factor-45 by granzyme B induces caspase-activated DNase release and DNA fragmentation. EMBO J (2001) 1.17
Gender differences in onset of illness, treatment response, course, and biologic indexes in first-episode schizophrenic patients. Am J Psychiatry (1995) 1.17
Granzymes A and B directly cleave lamins and disrupt the nuclear lamina during granule-mediated cytolysis. Proc Natl Acad Sci U S A (2001) 1.16
Correlates of substance misuse in patients with first-episode schizophrenia and schizoaffective disorder. Acta Psychiatr Scand (2001) 1.16
Psychobiologic correlates of treatment response in schizophrenia. Neuropsychopharmacology (1996) 1.14
Serum angiotensin-converting enzyme in leprosy and coccidioidomycosis. Ann Intern Med (1977) 1.14
Hepatocellular carcinoma and intermediate alpha1-antitrypsin deficiency (MZ phenotype). Am J Clin Pathol (1975) 1.13
Emergency thoracotomy: survival correlates with physiologic status. J Trauma (1992) 1.12
Serotonergic basis of antipsychotic drug effects in schizophrenia. Biol Psychiatry (1998) 1.11
A review of psychoactive substance use and abuse in schizophrenia. Patterns of drug choice. J Nerv Ment Dis (1987) 1.10
Profile of bronchospastic disease in Puerto Rican patients in New York City. A possible relationship to alpha 1-antitrypsin variants. Arch Intern Med (1990) 1.09
Effects of clozapine on auditory event-related potentials in schizophrenia. Biol Psychiatry (1998) 1.09
Angiotensin-I-converting enzyme and gallium scan in noninvasive evaluation of sarcoidosis. Ann Intern Med (1979) 1.08
Inhibition of leukocytic elastase from purulent sputum by alpha 1 -antitrypsin. J Lab Clin Med (1972) 1.08
Increased prevalence of the cavum septum pellucidum in magnetic resonance scans and post-mortem brains of schizophrenic patients. Psychiatry Res (1992) 1.07
The dentition of Abraham's people. Why Abraham left Mesopotamia. N Y State Dent J (1998) 1.06
Focal adhesion kinase is required for CXCL12-induced chemotactic and pro-adhesive responses in hematopoietic precursor cells. Leukemia (2007) 1.06
Serum angiotensin-converting enzyme: elevations in diabetes mellitus. Ann Intern Med (1980) 1.06
Screening for homozygous and heterozygous alpha 1-antitrypsin deficiency. Protein electrophoresis on cellulose acetate membranes. JAMA (1969) 1.06
Induction of rapid histone degradation by the cytotoxic T lymphocyte protease Granzyme A. J Biol Chem (2000) 1.05
Elastase, collagenase, emphysema, and alpha1-antitrypsin deficiency. Chest (1976) 1.04
Hierarchical diagnosis in chronic schizophrenia: a clinical study of co-occurring syndromes. Schizophr Bull (2000) 1.04
Striatal enlargement in rats chronically treated with neuroleptic. Biol Psychiatry (1998) 1.03
Recombinant human granzyme A binds to two putative HLA-associated proteins and cleaves one of them. Proc Natl Acad Sci U S A (1997) 1.03
Targeted treatment of depression-like symptoms in schizophrenia. Psychopharmacol Bull (1987) 1.03
Longitudinal evaluation of health care utilization and costs during the first three years after a new diagnosis of fibromyalgia. Curr Med Res Opin (2011) 1.00
Logical memory subtest of the Wechsler Memory Scale: age and education norms and alternate-form reliability of two scoring systems. J Clin Exp Neuropsychol (1987) 1.00
Mortality factors in geriatric blunt trauma patients. Arch Surg (1994) 0.99
CD3zeta and CD28 down-modulation on CD8 T cells during viral infection. Blood (2000) 0.99
Inhibitors and activators of leukocytic proteases in purulent sputum. Digestion of human lung and inhibition by alpha 1-antitrypsin. J Lab Clin Med (1971) 0.99
Bronchiectasis and homozygous alpha1-antitrypsin deficiency. Chest (1975) 0.99
Elevation of serum angiotensin-converting enzyme level. Occurrence in alcoholic liver disease. Arch Intern Med (1982) 0.98
Molecular abnormality of PI S variant of human alpha1-antitrypsin. Am J Hum Genet (1977) 0.98
Induction of human immunodeficiency virus (HIV)-specific CD8 T-cell responses by Listeria monocytogenes and a hyperattenuated Listeria strain engineered to express HIV antigens. J Virol (2000) 0.97